39th Pharmacovigilance India 2025

39th Pharmacovigilance India 2025 is organized by Virtue Insight and will be held from Nov 19 - 20, 2025 at Kohinoor Continental, Mumbai, Maharashtra, India.

5 Reasons to attend the event:

• Knowledge
  Gain insights from experts, researchers, and professionals on the latest pharma advancements.
• An Agenda Made For You
  High quality content that addresses your biggest challenges and uncovering hidden opportunities.
• Cutting-Edge Insights
  Explore the latest trends, innovations, and breakthroughs driving the future of the pharmaceutical industry.
• Networking
  Connect with peers, industry leaders, and collaborators to exchange ideas and explore new opportunities.
• Practical Takeaways
  Walk away with practical strategies, case studies, and proven best practices to apply in real-time.

KEY SPEAKERS:

SOMNATH BASU, Team Leader Reviewers of Drugs, National Regulatory Authority for Drugs (NRA India)

MAYUR PARMAR, Drugs Inspector (Deputy Collector, Gujarat Government), FDA

KHAUDEJA BANO, Vice President Combination Product Quality, Amgen (USA)

RAJ K BHOGAL, Sr. Director, R&D Business Strategy & Operations, Jazz Pharmaceuticals (UK)

PRASAD DESHMUKH, Vice President & Head Pharmacovigilance, Cipla

PRATIK SHAH, Vice President Medical Affairs, Bharat Serums and Vaccines

VIPIN SETHI, VP International Business, Head Global PV Function, Cadila

RAHUL GUPTA, Vice President, Regulatory Affairs, USV

MILIND ANTANI, Leader, Pharma & Healthcare, Nishith Desai Associates

GEETA SHANBHAG, VP - PV & Medico-Regulatory Affairs, Ipca Laboratories

SANTOSH TAUR, Director Medical Affairs, Ex-Chair, RWE Council, ISCR, Pfizer

VAIBHAV SALVI, Director & Head - Clinical Study Unit, India & South East Asia, Sanofi

PRABHAT SINHA, Director Government & Public Affairs, Boehringer Ingelheim

RISHI JAIN, Country Medical Head, Novartis

SHIRAZ KANDAWALLA, Associate Director, Ferring Pharmaceuticals

SAKSHI SHRIVASTAVA DESAI, Associate Director International PV Strategy Realization, Johnson & Johnson

MUKESH GORI, Associate Director -ESP Management CMO & PS, Novartis

INDU NAMBIAR, Pharmacovigilance Lead & Country Safety Head, Sanofi

SOURABH FULMALI, Global Medical Director – Respiratory, GSK

ROHINI PANDEY, Regional PV Head- SEA, Abbott

HARSHAD MALVE, Medical Head - Self-Care & Operations, Kenvue

JYOTSNA PATWARDHAN, Cluster Head Clinical/PV QA at Africa, Middle East, Turkey & India, Novartis

DHWANI DHOLAKIA, Division Head - Information Technology, Otsuka Pharmaceutical

JAMAL BAIG, Multi Country Safety Head, Sanofi

RENUKA NEOGI, Head & Deputy GM – Global Clinical Quality Management, Sun Pharma

SADANAND KULKARNI, Head- Medical, Regulatory, Vigilance & Quality, Fresenius Kabi

JEROZE DALAL, Head of Clinical Operations, Governance & Risk Management, GSK

MAYUR MAYBHATE, Head Medical Affairs, Alkem Laboratories

KRUNAL DALAL, Head Medical Affairs, GSK

RAHUL SOMANI, Head- Global Pharmacovigilance, Alkem Laboratories

APARNA PRABHUNE, Assistant General Manager – Regulatory Affairs, Wockhardt

VYNIE ANN RAO, Drug Safety & Risk Management Manager, Lupin

SUCHITA MORE, Associate Director Medical Affairs, MSD

CHITRA BARGAJE, Sr.GM, Global Head PV, Drug Safety & Risk Management, Lupin

GIRISH SANE, GM & Head Pharmacovigilance, Bristol Laboratories

KAVITA LAMROR, Partner, RWE & Digital Transformation, Maxis Clinical Sciences

SHRADDHA BHANGE, Senior Medical Safety Lead, Sandoz

KHOKAN DEBNATH, Sr. GM - Regulatory Affairs, Clinical Operations, PV & QA, Wockhardt

BIJENDER MISHRA, Sr. GM & CISO, Alkem Laboratories

RASHMI HEGDE, Former Executive Vice President Medical Affairs, GSK

JOYDEEP SENGUPTA, Global Pharmacovigilance - Site Head, Sun Pharmaceuticals

MARTINA GOMES, Head, Reg Affairs – CH, South Asia, Bayer

ANUJA JAWALE, Associate Director - RA/PV Strategic Engagements & Vendor Management, Organon

MEERA NAGARIA, Senior Data Scientist, Johnson & Johnson (Boston, USA)

SOUVIK CHATTERJEE, Senior Global Auditor, Novartis

MUGDHA SHAH, PV Audit and Inspection Readiness Manager, Sanofi

JYOTI KASHID, Manager, Global Patient Safety Operations, Lundbeck (Singapore)

VANSHIKA BRIJWANI, Manager Country Development Quality (CDQ), Novartis

KUSHAL SARDA, GM & Head - Medical Affairs, Clinical Research & PV, Shalina Healthcare

CHAITANYA KULKARNI, GM Pharmacovigilance, Marksans Pharma

VISHWAS SOVANI, Founder Director, Pharmawisdom

Plus more joining soon

FOCUSED AREAS:

• Market Trends - Critiques & Ways Forward
• Challenges / Opportunities
• Patient Safety / Patient Centricity
• RMP
• Quality
• Safety & Signal Detection
• Automation in PV
• Regulatory
• Impact of Technology AI, ML
• Audits & Inspection
• RWE / RWD
• Outsourcing